(Q34984049)

5 August 2017

1 reference

title

Use and interpretation of virological tests for hepatitis C. (English)

1 reference

5 August 2017

0 references

Jean-Michel Pawlotsky

series ordinal

1

object named as

Jean-Michel Pawlotsky

0 references

author name string

Jean-Michel Pawlotsky

series ordinal

1

1 reference

PubMed ID

12407578

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

36

1 reference

5 August 2017

5 Suppl 1

1 reference

5 August 2017

S65-73

1 reference

Molecular diagnosis of viral hepatitis

5 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Nucleic acid sequence-based amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Viral heterogeneity of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Low HCV replication levels in end-stage hepatitis C virus-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Efficacy of HCV core antigen detection during the preseroconversion period

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Clinical course of acute hepatitis C and changes in HCV markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Full or partial seroreversion in patients infected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

NAT of the United States and Canadian blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Large-scale analysis of hepatitis C virus serological typing assay: effectiveness and limits

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Determination of HCV genotype using two antibody assays and genome typing

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Typing of hepatitis C virus genomes by restriction fragment length polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Standardization of hepatitis C virus RNA quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Comparison between three quantitative assays in patients with chronic hepatitis C and their relevance in the prediction of response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Measuring hepatitis C viremia in clinical samples: can we trust the assays?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Treatment of acute hepatitis C with interferon alfa-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Mother-to-infant transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Mother-to-infant transmission of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

Therapy for acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36815

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36815

1 reference

5 August 2017

1 reference

PubMed ID

12407578